|
Molecular and immunological characterization of androgen receptor expression in different breast cancer subtypes. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - Caris Life Sciences |
Research Funding - Caris Life Sciences |
|
|
Employment - Caris Life Sciences |
Stock and Other Ownership Interests - Caris Life Sciences |
|
|
Honoraria - Gilead Sciences |
Consulting or Advisory Role - Caris Life Sciences; Daiichi Sankyo/Astra Zeneca; Pfizer |
Travel, Accommodations, Expenses - Gilead Sciences |
|
|
Employment - Caris Life Sciences |
|
|
Employment - Caris Life Sciences |
Stock and Other Ownership Interests - Caris Life Sciences |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Janssen |
|
|
Consulting or Advisory Role - AstraZeneca; Biovica; Daiichi Sankyo/Astra Zeneca; Daiichi Sankyo/Astra Zeneca; Genzyme; Gilead Sciences; Lilly; Novartis; Olaris; Pfizer; Regor Therapeutics Group; Stemline Therapeutics; Tempus; Tersera; Tersera |
Research Funding - Pfizer (Inst); Puma Biotechnology (Inst) |
Patents, Royalties, Other Intellectual Property - UpToDate: Authorship - served as a co-author on the subject of endocrine therapy for metastatic breast cancer and receive compensation as an author, less than a few hundred dollars a year. It does not affect my patient care or research. |
Travel, Accommodations, Expenses - SABCS; Total Health Conferencing |
|
|
Stock and Other Ownership Interests - HCA Healthcare |
Honoraria - Academy for Continued Healthcare Learning; DAVA Oncology; IntegrityCE; Med IQ; Medical Educator Consortium; MedPage Today; MJH Life Sciences; Remedy Health; WebMD/Medscape; Wolters Kluwer |
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Genentech; Gilead Sciences; Lilly; Menarini; Novartis; Pfizer; Seagen |
Research Funding - AstraZeneca/Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Novartis (Inst) |
Travel, Accommodations, Expenses - Loxo/Lilly; Novartis; Paxman |
Other Relationship - Dr. Susan Love Foundation for Breast Cancer Research |
|
|
Employment - Caris Life Sciences |
Leadership - Caris Life Sciences |
Stock and Other Ownership Interests - LifeOmic |
Patents, Royalties, Other Intellectual Property - Patents developed at Caris Life Sciences (Inst) |
Travel, Accommodations, Expenses - Caris Life Sciences |
|
|
Employment - Caris Life Sciences |
Leadership - Caris Life Sciences; Syndax; Tessa Therapeutics |
Stock and Other Ownership Interests - Caris Life Sciences; Pionyr; Syndax |
Consulting or Advisory Role - Caris Life Sciences; Syndax |
Travel, Accommodations, Expenses - Caris Life Sciences |
|
|
Honoraria - Bayer; Boehringer Ingelheim; Fulgent Genetics; G1 THerapeutics; Isofol Medical; Jazz Pharmaceuticals; Merck Serono; Oncocyte; Roche |
Consulting or Advisory Role - 3T BioSciences; Bayer; BMS; Fulgent Genetics; GlaxoSmithKline; Merck Serono; Roche |
Travel, Accommodations, Expenses - Bayer; BMS; Merck Serono |
|
Evanthia T. Roussos Torres |
Stock and Other Ownership Interests - Synaptical |